rheumatoid arthritis . effects of gold salts in antigens with various toxic Association of different HLA and

An association of gold induced proteinuria with HLA-D(R)3 has been reported. To investigate other possible relationships between gold toxicity and HLA antigens we studied 85 patients with rheumatoid arthritis (RA) divided into four subgroups: patients with gold induced interstitial pneumonitis, mucocutaneous lesions, proteinuria, and patients without gold toxicity. The HLA frequencies in patient groups and 283 healthy controls were compared in different pairwise combinations. Gold induced pneumonitis was associated with HLA-B40 and Dwl. An association between gold induced proteinuria and HLA-Dw3 was also seen. The increased prevalence of Dw4 in RA was observed only in the control patient group without gold induced side effects. The frequencies of HLA-B7 and Dw2 were decreased in all patient groups compared with the control population. These results further support the view of the heterogeneity of RA as manifested by the unique HLA associations with resistance and susceptibility to gold induced side effects characterising different subgroups.

[1]  P. Stastny.  Mixed Lymphocyte Culture Typing Cells from Patients with Rheumatoid Arthritis , 2008 .

[2]  W. Thomson,et al.  Rheumatoid arthritis-joint report , 1992 .

[3]  H. Valkenburg,et al.  Epidemiological study of HLA and GM in rheumatoid arthritis and related symptoms in an open Dutch population. , 1984, Annals of the rheumatic diseases.

[4]  A. Zeevi,et al.  Serological and cellular definition of a new HLA-DR associated determinant, MC1, and its association with rheumatoid arthritis. , 1984, Human immunology.

[5]  I. Guggenmoos‐Holzmann,et al.  Association of HLA-Bw35 with mucocutaneous lesions in rheumatoid arthritis patients undergoing sodium aurothiomalate therapy. , 1984, Arthritis & Rheumatism.

[6]  G. Alarcón,et al.  DR antigens and gold toxicity in white rheumatoid arthritis patients. , 1984, Arthritis and rheumatism.

[7]  M. Corbett,et al.  Association of HLA-DR4/Dw4 and DR2/Dw2 with radiologic changes in a prospective study of patients with rheumatoid arthritis. Preferential relationship with HLA-Dw rather than HLA-DR specificities. , 1984, Arthritis and rheumatism.

[8]  T. Pettersson,et al.  Alveolitis during chrysotherapy for rheumatoid arthritis. , 2009, Acta medica Scandinavica.

[9]  J. Ilonen,et al.  HLA-Dw1 and BfF as protective markers in multiple sclerosis , 1983, Journal of Neuroimmunology.

[10]  E. Thorsby,et al.  HLA DR antigens and gold toxicity. , 1983, Annals of the rheumatic diseases.

[11]  C. Werning.  [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.

[12]  J. Dausset,et al.  HLA system and side effects of gold salts and D-penicillamine treatment of rheumatoid arthritis. , 1982, Annals of the rheumatic diseases.

[13]  M. Yaron,et al.  Association of HLA-Aw31 and HLA-DR1 with adult rheumatoid arthritis. , 1982, Annals of the rheumatic diseases.

[14]  J. Woodrow,et al.  DR antigens and rheumatoid arthritis: a study of two populations. , 1981, British medical journal.

[15]  S. Javaheri,et al.  Idiopathic pulmonary fibrosis in monozygotic twins. The importance of genetic predisposition. , 1980, Chest.

[16]  K. Welsh,et al.  HLA-DR antigens and toxic reaction to sodium aurothiomalate and D-penicillamine in patients with rheumatoid arthritis. , 1980, The New England journal of medicine.

[17]  J. Karvonen,et al.  Psoriasis and HLA‐Cw6 , 1980, The British journal of dermatology.

[18]  N. Morling,et al.  HLA--Dw4 and rheumatoid arthritis. , 2008, Tissue antigens.

[19]  M. Torkko,et al.  Pulmonary damage associated with gold therapy. A report of two cases. , 1979, Scandinavian journal of respiratory diseases.

[20]  A. de la Chapelle,et al.  Stimulatory and cytotoxic activity on human adult and fetal lymphocytes by heterologous antihuman fetal lymphocyte sera. , 1979, Transplantation.

[21]  H. Kalimo,et al.  Pulmonary Reactions Induced By Gold Therapy , 1979 .

[22]  K. Vuori,et al.  PULMONARY INFILTRATES ASSOCIATED WITH GOLD THERAPY , 1979, Duodecim lääketieteellinen aikakauskirja.

[23]  G. Panayi,et al.  Genetic basis of rheumatoid disease: HLA antigens, disease manifestations, and toxic reactions to drugs. , 1978, British medical journal.

[24]  P. Stastny.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. , 1978, The New England journal of medicine.

[25]  C. Mueller-Eckhardt,et al.  AGRANULOCYTOSIS, LEVAMISOLE, AND HLA-B27 , 1977, The Lancet.

[26]  H. Isomäki,et al.  Some characteristics of RA patients with and without side effects due to gold treatment. , 1977, Scandinavian Journal of Rheumatology.

[27]  R. Winterbauer,et al.  Diffuse pulmonary injury associated with gold treatment. , 1976, The New England journal of medicine.

[28]  H. Isomäki,et al.  HL-A 27 AND RHEUMATOID ARTHRITIS , 1974 .

[29]  A. Svejgaard,et al.  HL-A antigens and diseases. I. Multiple sclerosis. , 2008, Tissue antigens.

[30]  G. A. Bennett,et al.  1958 Revision of diagnostic criteria for rheumatoid arthritis. , 1959, Bulletin on the rheumatic diseases.